Novel strategies for the treatment of small-cell lung carcinoma

Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin

(2010) Chi-Hui Tang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy

(2010) Roland Hubaux et al.   EUROPEAN JOURNAL OF CANCER

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis

(2010) Linlang Guo et al.   EUROPEAN JOURNAL OF CANCER

Phase II Study of Cediranib (AZD 2171), an Inhibitor of the Vascular Endothelial Growth Factor Receptor, for Second-Line Therapy of Small Cell Lung Cancer (National Cancer Institute #7097)

(2010) Suresh S. Ramalingam et al.   Journal of Thoracic Oncology

Sorafenib in Platinum-Treated Patients with Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group (SWOG 0435) Phase II Trial

(2010) Barbara J. Gitlitz et al.   Journal of Thoracic Oncology

Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors

(2010) J. Voortman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001

(2009) M. Marinov et al.   CLINICAL CANCER RESEARCH

DIFFERENTIALLY EXPRESSED MicroRNAs IN SMALL CELL LUNG CANCER

(2009) Edit Miko et al.   EXPERIMENTAL LUNG RESEARCH

Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer

(2009) John R. Eckardt et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

(2009) Primo N. Lara et al.   JOURNAL OF CLINICAL ONCOLOGY

Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab

(2009) David R. Spigel et al.   JOURNAL OF CLINICAL ONCOLOGY

Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

(2009) Siow Ming Lee et al.   JNCI-Journal of the National Cancer Institute

Hypoxia Inducible Factor-1alpha and Vascular Endothelial Growth Factor in Biopsies of Small Cell Lung Carcinoma

(2009) M. Ioannou et al.   LUNG

The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer

(2009) M. C. Crisanti et al.   MOLECULAR CANCER THERAPEUTICS

A small-cell lung cancer genome with complex signatures of tobacco exposure

(2009) Erin D. Pleasance et al.   NATURE

Twenty-Seven Years of Phase III Trials for Patients with Extensive Disease Small-Cell Lung Cancer: Disappointing Results

(2009) Isao Oze et al.   PLoS One

Randomized Phase II Study of Carboplatin and Etoposide With or Without thebcl-2Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

(2008) Charles M. Rudin et al.   JOURNAL OF CLINICAL ONCOLOGY

Lung Cancer

(2008) Roy S. Herbst et al.   NEW ENGLAND JOURNAL OF MEDICINE

Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt

(2007) Juddi Yeh et al.   LUNG CANCER